{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:31:14Z","timestamp":1791984674665,"version":"4.4.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The use of magnetic resonance imaging (MRI) to estimate tissue iron was conceived in the 1980s, but has only become a practical reality in the last decade. The technique is most often used to estimate hepatic and cardiac iron in patients with transfusional siderosis and has largely replaced liver biopsy for liver iron quantification. However, the ability of MRI to quantify extrahepatic iron has had a greater impact on patient care and on our understanding of iron overload pathophysiology. Iron cardiomyopathy used to be the leading cause of death in thalassemia major, but is now relatively rare in centers with regular MRI screening of cardiac iron, through earlier recognition of cardiac iron loading. Longitudinal MRI studies have demonstrated differential kinetics of uptake and clearance among the difference organs of the body. Although elevated serum ferritin and liver iron concentration (LIC) increase the risk of cardiac and endocrine toxicities, some patients unequivocally develop extrahepatic iron deposition and toxicity despite having low total body iron stores. These observations, coupled with the advent of increasing options for iron chelation therapy, are allowing clinicians to more appropriately tailor chelation therapy to individual patient needs, producing greater efficacy with fewer toxicities. Future frontiers in MRI monitoring include improved prevention of endocrine toxicities, particularly hypogonadotropic hypogonadism and diabetes.<\/jats:p>","DOI":"10.1182\/asheducation-2011.1.443","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T20:33:13Z","timestamp":1323289993000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":110,"title":["Impact of Iron Assessment by MRI"],"prefix":"10.1182","volume":"2011","author":[{"given":"John C.","family":"Wood","sequence":"first","affiliation":[{"name":"Children's Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111717262397000_B1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.30.5.698","article-title":"Late cardiac complications of chronic, sever, refractory anemia","volume":"30","author":"Engle","year":"1964","journal-title":"Circulation"},{"issue":"10","key":"2019111717262397000_B2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"issue":"9220","key":"2019111717262397000_B3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","article-title":"Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register","volume":"355","author":"Modell","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"2019111717262397000_B4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2003-08-2841","article-title":"Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major","volume":"104","author":"Davis","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111717262397000_B5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","article-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"issue":"3","key":"2019111717262397000_B6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.148.3.6192464","article-title":"Nuclear magnetic resonance imaging of experimentally induced liver disease","volume":"148","author":"Stark","year":"1983","journal-title":"Radiology"},{"issue":"9332","key":"2019111717262397000_B7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"2019111717262397000_B8","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2019111717262397000_B9","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111717262397000_B10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2009-11-250308","article-title":"The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores","volume":"116","author":"Wood","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111717262397000_B11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MOH.0b013e3280d2b76b","article-title":"Magnetic resonance imaging measurement of iron overload","volume":"14","author":"Wood","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"2019111717262397000_B12","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2+ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"issue":"14","key":"2019111717262397000_B13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2+ magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"2019111717262397000_B14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","article-title":"Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance","volume":"105","author":"St Pierre","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111717262397000_B15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/mrm.10735","article-title":"Mimicking liver iron overload using liposomal ferritin preparations","volume":"51","author":"Wood","year":"2004","journal-title":"Mag Res Med"},{"issue":"3","key":"2019111717262397000_B16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mrm.22657","article-title":"Relaxivity-iron calibration in hepatic iron overload: Probing underlying biophysical mechanisms using a Monte Carlo model","volume":"65","author":"Ghugre","year":"2011","journal-title":"Magn Reson Med"},{"issue":"6","key":"2019111717262397000_B17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/jmri.22553","article-title":"Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia","volume":"33","author":"Cheung","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2019111717262397000_B18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2+ cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111717262397000_B19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jmri.10332","article-title":"A single breath-hold multiecho T2+ cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2019111717262397000_B20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmri.10396","article-title":"Interscanner reproducibility of cardiovascular magnetic resonance T2+ measurements of tissue iron in thalassemia","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2019111717262397000_B21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10554-005-0651-2","article-title":"Intercentre reproducibility of magnetic resonance T2+ measurements of myocardial iron in thalassaemia","volume":"21","author":"Westwood","year":"2005","journal-title":"Int J Cardiovasc Imaging"},{"issue":"23","key":"2019111717262397000_B22","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2+) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"issue":"20","key":"2019111717262397000_B23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2+ magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"2019111717262397000_B24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3324\/haematol.2010.031468","article-title":"Continued improvement in myocardial T2+ over 2 years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload","volume":"96","author":"Pennell","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"2019111717262397000_B25","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s002340100634","article-title":"Pituitary gland height evaluated by MR in patients with beta-thalassemia major: a marker of pituitary gland function","volume":"43","author":"Argyropoulou","year":"2001","journal-title":"Neuroradiology"},{"issue":"6","key":"2019111717262397000_B26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2214\/ajr.175.6.1751567","article-title":"T2 relaxation rate as an index of pituitary iron overload in patients with beta-thalassemia major","volume":"175","author":"Argyropoulou","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"2019111717262397000_B27","article-title":"Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients","author":"de Assis","journal-title":"Eur J Radiol"},{"issue":"19","key":"2019111717262397000_B28","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2009-06-225615","article-title":"Pancreatic iron loading predicts cardiac iron loading in thalassemia major","volume":"114","author":"Noetzli","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111717262397000_B29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.104.504415","article-title":"Cardiac iron determines cardiac T2+, T2, and T1 in the gerbil model of iron cardiomyopathy","volume":"112","author":"Wood","year":"2005","journal-title":"Circulation"},{"key":"2019111717262397000_B30","first-page":"249","article-title":"Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF)","volume":"2","author":"De Sanctis","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"issue":"7","key":"2019111717262397000_B31","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2008-04-148767","article-title":"Longitudinal analysis of heart and liver iron in thalassemia major","volume":"112","author":"Noetzli","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111717262397000_B32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000203853","article-title":"Results of long-term iron-chelating therapy","volume":"95","author":"Gabutti","year":"1996","journal-title":"Acta Haematol"},{"issue":"5","key":"2019111717262397000_B33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111717262397000_B34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111717262397000_B35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V88.2.705.bloodjournal882705","article-title":"Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy","volume":"88","author":"Porter","year":"1996","journal-title":"Blood"},{"issue":"7","key":"2019111717262397000_B36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3324\/haematol.2010.032862","article-title":"Relationship between LPI, LIC, and cardiac response in a deferasirox monotherapy trial","volume":"96","author":"Wood","year":"2011","journal-title":"Haematologica"},{"issue":"1","key":"2019111717262397000_B37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2+ cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"2019111717262397000_B38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1365-2141.2000.02298.x","article-title":"Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major","volume":"110","author":"Telfer","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111717262397000_B39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2002-06-1704","article-title":"Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias","volume":"101","author":"Jensen","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111717262397000_B40","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2002-09-2754","article-title":"Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool","volume":"101","author":"Jensen","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111717262397000_B41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.11768","article-title":"A T2+ magnetic resonance imaging study of pancreatic iron overload in thalassemia major","volume":"93","author":"Au","year":"2008","journal-title":"Haematologica"},{"key":"2019111717262397000_B42","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood.V112.11.3876.3876","article-title":"Pancreatic iron and pancreatic function in thalassemia [Abstract]","volume":"112","author":"Noetzli","year":"2008","journal-title":"Blood"},{"key":"2019111717262397000_B43","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0268-960X(08)70004-3","article-title":"Cardiac iron across different transfusion-dependent diseases","volume":"22","author":"Wood","year":"2008","journal-title":"Blood Rev"},{"issue":"1","key":"2019111717262397000_B44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2010.10.005","article-title":"Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2+ in multi-transfused patients with thalassemia and acquired anemias","volume":"22","author":"Fragasso","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"2","key":"2019111717262397000_B45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.2010.08476.x","article-title":"Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major","volume":"152","author":"Noetzli","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111717262397000_B46","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111717262397000_B47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06332.x","article-title":"Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease","volume":"135","author":"Fung","year":"2006","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111717262397000_B48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2141.2009.07793.x","article-title":"Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America","volume":"146","author":"Vogiatzi","year":"2009","journal-title":"Br J Haematol"},{"key":"2019111717262397000_B49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2010.05545.x","article-title":"Predicting pituitary iron and endocrine dysfunction","volume":"1202","author":"Wood","year":"2010","journal-title":"Ann N Y Acad Sci"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/443\/1494055\/bep00111000443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/443\/1494055\/bep00111000443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T22:26:57Z","timestamp":1574029617000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2011\/1\/443\/96441\/Impact-of-Iron-Assessment-by-MRI"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2011.1.443","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]}}}